| Exosomes play roles in sequential processes of tumor metastasis K Li, Y Chen, A Li, C Tan, X Liu International journal of cancer 144 (7), 1486-1495, 2019 | 147 | 2019 |
| Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects KY Li, JL Yuan, D Trafton, JX Wang, N Niu, CH Yuan, XB Liu, L Zheng Chronic diseases and translational medicine 6 (01), 6-17, 2020 | 63 | 2020 |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas II, T Xia, G Mo, ... Cancer Cell 40 (11), 1374 - 1391, 2022 | 53 | 2022 |
| STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma Y Lan, J Han, Y Wang, J Wang, G Yang, K Li, R Song, T Zheng, Y Liang, ... Cell Death & Disease 9 (2), 236, 2018 | 50 | 2018 |
| N‐myc downstream‐regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA‐181c negative feedback pathway J Wang, C Xie, S Pan, Y Liang, J Han, Y Lan, J Sun, K Li, B Sun, G Yang, ... Hepatology 64 (5), 1606-1622, 2016 | 48 | 2016 |
| CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma J Wang, MT Saung, K Li, J Fu, K Fujiwara, N Niu, S Muth, J Wang, Y Xu, ... Journal of Experimental Medicine 219 (5), e20211631, 2022 | 29 | 2022 |
| Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses T Xia, K Li, N Niu, Y Shao, D Ding, DL Thomas, H Jing, K Fujiwara, H Hu, ... Journal of Hematology & Oncology 15 (1), 37, 2022 | 29 | 2022 |
| Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer K Fujiwara, MT Saung, H Jing, B Herbst, MK Zarecki, S Muth, A Wu, ... Journal for Immunotherapy of cancer 8 (2), 2020 | 27 | 2020 |
| Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis J Han, C Xie, T Pei, J Wang, Y Lan, K Huang, Y Cui, F Wang, J Zhang, ... Cell death & disease 8 (4), e2736-e2736, 2017 | 27 | 2017 |
| Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-programmed cell death protein 1 therapy AB Blair, J Wang, J Davelaar, A Baker, K Li, N Niu, J Wang, Y Shao, ... Gastroenterology 163 (5), 1267-1280. e7, 2022 | 24 | 2022 |
| Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells A Osipov, AB Blair, J Liberto, J Wang, K Li, B Herbst, Y Xu, S Li, N Niu, ... Cancer biology & medicine 18 (1), 206, 2021 | 22 | 2021 |
| Chimeric antigen receptor–engineered T cells for liver cancers, progress and obstacles K Li, Y Lan, J Wang, L Liu Tumor Biology 39 (3), 1010428317692229, 2017 | 18 | 2017 |
| Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model P Li, N Rozich, J Wang, J Wang, Y Xu, B Herbst, R Yu, S Muth, N Niu, K Li, ... Cancer letters 539, 215722, 2022 | 15 | 2022 |
| Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma K Li, J Wang, J Han, Y Lan, C Xie, S Pan, L Liu Oncotarget 7 (46), 76108, 2016 | 13 | 2016 |
| A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable … T Heumann, C Judkins, K Li, SJ Lim, J Hoare, R Parkinson, H Cao, ... Nature communications 14 (1), 3650, 2023 | 11 | 2023 |
| Primary hepatic myelolipoma: a case report and review of the literature KY Li, AL Wei, A Li World Journal of Clinical Cases 8 (19), 4615, 2020 | 5 | 2020 |
| The implications of focal adhesion kinase (FAK) on T-cell populations in immunotherapy treated pancreatic ductal adenocarcinoma (PDAC) A Osipov, K Li, D Choi, N Rozich, D Thomas, L Zheng Pancreas 48 (10), 1503-1503, 2019 | 2 | 2019 |
| Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells J Wang, J Gai, T Zhang, N Niu, H Qi, DL Thomas, K Li, T Xia, C Rodriguez, ... Science Advances 10 (6), eadk1827, 2024 | 1 | 2024 |
| Successful Neoadjuvant Chemotherapy for Small-Cell Neuroendocrine Carcinoma of the Pancreas: A Case Report K Li, J Yuan, Y Li, H Zhang, X Liu, N Ke Frontiers in Oncology 11, 719422, 2021 | 1 | 2021 |
| AB042. P013. LncRNAPTCHD3P1 enhances chemosensitivity of gemcitabine in pancreatic cancer and inhibits cancer cell proliferation and metastasis via inhibiting Warburg effect J Wang, K Li Annals of Pancreatic Cancer 1 (4), 2018 | 1 | 2018 |
